Facebook
X
LinkedIn
ForwardDDW 2025 Review
Meeting Agenda
7:15 am – 7:45 am Breakfast
7:45 am - 8:30 am Impact of AI on the Endoscopic Practice in Gastroenterology: Hype and Reality
V. Rajesh Konjeti, MBBS
8:35 am- 9:20 am From Bleeding to Healing: Innovations in Endoscopy
Kshitij Thakur, MBBS
9:25 am - 10:10 am Innovations and Updates in Pancreato-Biliary Endoscopy
Ingrid Beyruth Schwartz, MD
10:15 am – 11am Best of Liver Diseases
Nimish Thakral, MBBS
11:05 am 11:50 am IBD Therapeutics
Courtney Perry, DO
11:50 am – 12:25 pm Lunch Break (may continue eating while talks resume)
12:30 pm- 1:15 pm IBD Beyond Therapeutics
Deborah Flomenhoft, MD
1:20 pm – 2:05 pm Fellows Corner: A Day in the GI Office: What to Do Next for Common Presentations
Alla Grigorian, MD
Target Audience
Gastroenterology Physicians, Fellows, and Midlevel Practitioners.
Learning Objectives
Upon completion of this conference, participants will be able to:
- Evaluate the current and potential applications of artificial intelligence in endoscopic practice within gastroenterology.
- Distinguish between the validated clinical benefits and the overestimated claims surrounding AI technologies in this field.
- Identify new diagnostic and therapeutic endoscopic approaches for upper and lower GI bleeding presented at DDW 2025.
- Compare recent clinical trial outcomes related to timing and techniques in endoscopic management of GI bleeding.
- Apply updated evidence-based strategies to the endoscopic management of acute GI bleeding in clinical scenarios.
- Describe recent research findings and clinical updates from Digestive Disease Week (DDW) related to pancreatobiliary diseases.
- Identify emerging diagnostic tools and treatment strategies for conditions such as pancreatitis, benign pancreatic cysts and neoplasms, pancreatic cancer, benign and malignant biliary tract obstruction, other benign biliary disorders such as choledocholithiasis, cholangitis, biliary leaks, choledocho fistulas.
- Apply updated clinical guidelines and evidence-based practices to improve the management of patients with pancreatobiliary diseases
- Diagnose and risk-stratify patients with MASLD, triaging them for appropriate treatment based on fibrosis stage.
- Integrate new and evolving evidence towards their approach to MASLD treatment.
- Review recent advances in endoscopic therapies within the field of Hepatology including EUS guided liver biopsy, portal pressure measurement and treatment of Gastric varices.
- Review recent updates in Hepatitis C management and care delivery
- Review the latest updates in therapeutic management of Inflammatory Bowel Diseases
- Assess the use of frequent other medications in IBD and effects on IBD
- Use complementary therapies in IBD
- Explain when and how to test to sucrose isomaltase deficiency
- Describe the clinical approach to hiccups and belching when endoscopy is unrevealing
- Outline what to do with refractory SIBO
- Identify mimickers of IBS (alpha-gal, EGID, and others)
Available Credit
- 5.25 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Live activity is designated for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.